Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities - PubMed (original) (raw)
. 1991 Jan 5;266(1):406-12.
Affiliations
- PMID: 1702425
Free article
Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities
E S Furfine et al. J Biol Chem. 1991.
Free article
Abstract
Human immunodeficiency virus reverse transcriptase.RNase H (RT.RNase H) has an RNA hydrolysis specificity which was influenced both by the sequence of the DNA primer-RNA template and by binding of the polymerase active site to the primer 3' terminus. RT.RNase H selectively hydrolyzed the phosphodiester bond between the 15th and 16th ribonucleotide back from the ribonucleotide that is complementary to the primer 3'-terminal deoxynucleotide. The cleavage site for RT.RNase H remained a fixed distance behind the 3'-primer terminus as the polymerase extended the primer. This cleavage was not strongly affected by the position of the DNA primer on the template nor was it affected by reducing the primer length from 40 to 25 nucleotides. These results suggest that the distance between the RNase H and polymerase active sites corresponds to the length of a 15-16-nucleotide DNA-RNA heteroduplex. Since one helical turn is approximately 10 nucleotides, the distance between the active sites is 1.5 helical turns of heteroduplex. Therefore, the two active sites (catalyzing reactions on opposite strands) bind the same side of the RNA-DNA double helix. RT.RNase H also showed some sequence dependence for the site of hydrolysis. This sequence dependence has not been fully characterized. The rate of RT.RNase H cleavage was weakly inhibited by the next coded deoxynucleoside triphosphate following the incorporation of a dideoxynucleotide.
Similar articles
- Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNA(Lys3)-primer excision.
Furfine ES, Reardon JE. Furfine ES, et al. Biochemistry. 1991 Jul 23;30(29):7041-6. doi: 10.1021/bi00243a001. Biochemistry. 1991. PMID: 1713059 - Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.
DeStefano JJ, Mallaber LM, Fay PJ, Bambara RA. DeStefano JJ, et al. Nucleic Acids Res. 1993 Sep 11;21(18):4330-8. doi: 10.1093/nar/21.18.4330. Nucleic Acids Res. 1993. PMID: 7692401 Free PMC article. - Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
Ben-Artzi H, Zeelon E, Gorecki M, Panet A. Ben-Artzi H, et al. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):927-31. doi: 10.1073/pnas.89.3.927. Proc Natl Acad Sci U S A. 1992. PMID: 1371014 Free PMC article. - HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA.
Götte M, Fackler S, Hermann T, Perola E, Cellai L, Gross HJ, Le Grice SF, Heumann H. Götte M, et al. EMBO J. 1995 Feb 15;14(4):833-41. doi: 10.1002/j.1460-2075.1995.tb07061.x. EMBO J. 1995. PMID: 7533725 Free PMC article. - Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.
Götte M, Rausch JW, Marchand B, Sarafianos S, Le Grice SF. Götte M, et al. Biochim Biophys Acta. 2010 May;1804(5):1202-12. doi: 10.1016/j.bbapap.2009.07.020. Epub 2009 Aug 7. Biochim Biophys Acta. 2010. PMID: 19665597 Free PMC article. Review.
Cited by
- Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity.
Ilina T, Labarge K, Sarafianos SG, Ishima R, Parniak MA. Ilina T, et al. Biology (Basel). 2012 Oct 19;1(3):521-41. doi: 10.3390/biology1030521. Biology (Basel). 2012. PMID: 23599900 Free PMC article. - Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.
Champoux JJ, Schultz SJ. Champoux JJ, et al. FEBS J. 2009 Mar;276(6):1506-16. doi: 10.1111/j.1742-4658.2009.06909.x. Epub 2009 Feb 18. FEBS J. 2009. PMID: 19228195 Free PMC article. Review. - Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.
Wu W, Henderson LE, Copeland TD, Gorelick RJ, Bosche WJ, Rein A, Levin JG. Wu W, et al. J Virol. 1996 Oct;70(10):7132-42. doi: 10.1128/JVI.70.10.7132-7142.1996. J Virol. 1996. PMID: 8794360 Free PMC article.